Cargando…
Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn’s disease medications and hepatosplenic T-cell lymphoma
BACKGROUND: To identify demographic and clinical characteristics associated with cases of hepatosplenic T-cell lymphoma (HSTCL) in patients with Crohn’s disease, and to assess strength of evidence for a causal relationship between medications and HSTCL in Crohn’s disease. METHODS: We identified case...
Autores principales: | Selvaraj, Saranya A, Chairez, Elizabeth, Wilson, Lisa M, Lazarev, Mark, Bass, Eric B, Hutfless, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710465/ https://www.ncbi.nlm.nih.gov/pubmed/23826928 http://dx.doi.org/10.1186/2046-4053-2-53 |
Ejemplares similares
-
Hemophagocytic lymphohistiocytosis associated with hepatosplenic T-cell lymphoma: case report
por: Paes, Vitor Ribeiro, et al.
Publicado: (2014) -
Hepatosplenic T-cell lymphoma in a 47-year-old Crohn’s disease patient on thiopurine monotherapy
por: van de Meeberg, Maartje M, et al.
Publicado: (2016) -
How Does It Look in an Autopsy? Hepatosplenic T-Cell Lymphoma in a Patient with Crohn’s Disease on Azathioprine
por: Rastogi, Pulkit, et al.
Publicado: (2020) -
Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report
por: Wang, Xing-Tong, et al.
Publicado: (2020) -
Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis
por: Gabali, Ali M, et al.
Publicado: (2014)